Relmada Therapeutics, Inc. (RLMD): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$182.05M
Year ended 2020-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $182.05M | +114.6% | 2021-03-24, From 2020-01-01 |
| 2019-12-31 | $84.85M | n/a | 2021-03-24, From 2019-01-01 |
| No annual figure between 2018-06-30 and 2019-12-31. | |||
| 2018-06-30 | $12.4K | -75.1% | 2019-09-24, From 2017-07-01 |
| 2017-06-30 | $49.7K | -91.2% | 2018-09-28, From 2016-07-01 |
| 2016-06-30 | $562.3K | n/m | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | $23.3K | n/a | 2016-09-09, From 2014-07-01 |
| No annual figure between 2013-12-31 and 2015-06-30. | |||
| 2013-12-31 | $8.9K | n/a | 2015-09-11, From 2013-01-01 |